{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:35:32Z","timestamp":1764401732710},"reference-count":13,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,7]]},"abstract":"<jats:p>Nigeria has the largest population at risk for lymphatic filariasis (LF) in Africa. This study used a transmission assessment survey (TAS) to determine whether mass drug administration (MDA) for LF could stop in 21 districts, divided into four evaluation units (EUs), of Plateau and Nasarawa States, Nigeria, after 8\u201312 years of annual albendazole\u2013ivermectin treatment. A total of 7,131 first- and second-year primary school children (approximately 6\u20137 years old) were tested for LF antigen by immunochromatographic test (ICT) from May to June 2012. The target sample size of 1,692 was exceeded in each EU (range = 1,767\u20131,795). A total of 25 (0.4%) individuals were ICT positive, with the number of positives in each EU (range = 3\u201311) less than the TAS cutoff of 20, meaning that LF transmission had been reduced below sustainable levels. As a result, 3.5 million annual albendazole\u2013ivermectin treatments were halted in 2013. Combined with the previous halt of MDA for LF in other parts of Plateau and Nasarawa, these are the first Nigerian states to stop LF MDA statewide. Posttreatment surveillance is ongoing to determine if LF transmission has been interrupted.<\/jats:p>","DOI":"10.4269\/ajtmh.16-0843","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T07:00:54Z","timestamp":1500966054000},"page":"677-680","source":"Crossref","is-referenced-by-count":5,"title":["Criteria to Stop Mass Drug Administration for Lymphatic Filariasis Have Been Achieved Throughout Plateau and Nasarawa States, Nigeria"],"prefix":"10.4269","volume":"97","author":[{"given":"Abel","family":"Eigege","sequence":"first","affiliation":[{"name":"The Carter Center, Jos, Plateau State, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin S.","family":"Evans","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"},{"name":"United States Agency for International Development (USAID), Washington, District of Columbia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Noland","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Davies","sequence":"additional","affiliation":[{"name":"Federal Ministry of Health, Abuja, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Umaru","sequence":"additional","affiliation":[{"name":"The Carter Center, Jos, Plateau State, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon E.","family":"Adelamo","sequence":"additional","affiliation":[{"name":"The Carter Center, Jos, Plateau State, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulus","family":"Mancha","sequence":"additional","affiliation":[{"name":"The Carter Center, Jos, Plateau State, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"King","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"},{"name":"Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel S.","family":"Miri","sequence":"additional","affiliation":[{"name":"The Carter Center, Jos, Plateau State, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Okoeguale","sequence":"additional","affiliation":[{"name":"Federal Ministry of Health, Abuja, Nigeria;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily P.","family":"Griswold","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank O.","family":"Richards Jr.","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"year":"2011","key":"b1"},{"key":"b2","series-title":"Wkly Epidemiol Rec","first-page":"489","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2014","volume":"90","year":"2015"},{"key":"b3","series-title":"Am J Trop Med Hyg","first-page":"266","article-title":"Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria","volume":"67","author":"Hopkins","year":"2002"},{"key":"b4","series-title":"PLoS Negl Trop Dis","first-page":"e1346","article-title":"Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria","volume":"5","author":"Richards","year":"2011"},{"key":"b5","series-title":"Am J Trop Med Hyg","first-page":"272","article-title":"Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria","volume":"87","author":"King","year":"2012"},{"year":"2004","key":"b6"},{"key":"b7","series-title":"Lancet Infect Dis","first-page":"223","article-title":"Mathematical modelling and the control of lymphatic filariasis","volume":"4","author":"Michael","year":"2004"},{"key":"b8","series-title":"PLoS Negl Trop Dis","first-page":"e2508","article-title":"Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria","volume":"7","author":"Eigege","year":"2013"},{"key":"b9","series-title":"PLoS Negl Trop Dis","first-page":"e3113","article-title":"Status of onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision","volume":"8","author":"Evans","year":"2014"},{"key":"b10","series-title":"Invert Neurosci","first-page":"7","article-title":"How do the macrocyclic lactones kill filarial nematode larvae?","volume":"16","author":"Wolstenholme","year":"2016"},{"year":"2016","key":"b11"},{"key":"b12","series-title":"Parasit Vectors","first-page":"300","article-title":"A case study of risk factors for lymphatic filariasis in the Republic of Congo","volume":"7","author":"Chesnais","year":"2014"},{"year":"2017","key":"b13"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/3\/article-p677.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/3\/article-p677.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/3\/article-p677.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T16:28:56Z","timestamp":1722443336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/3\/article-p677.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":13,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.16-0843","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"type":"print","value":"0002-9637"},{"type":"electronic","value":"1476-1645"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}